Patents by Inventor Yunqiu Yang

Yunqiu Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12133857
    Abstract: The present disclosure discloses a method for prolonging half-life of theanine in vivo. According to the present disclosure, a specific theanine glycoside compound formed by modification with a specific monosaccharide is used for prolonging the half-life of the theanine in vivo, which can be used for preparing sustained release drugs, prolonging action time of drugs, reducing administration frequency and improving compliance of patients. With the method of the present disclosure, the theanine glycoside compound obtained after modification can have a broad application prospect and a high commercial value in scientific research and clinical application.
    Type: Grant
    Filed: May 29, 2024
    Date of Patent: November 5, 2024
    Assignee: Anhui Agricultural University
    Inventors: Yijun Wang, Zhipeng Kan, Xiaochun Wan, Jinbao Huang, Kangyi Zhang, Yunqiu Yang, Xiaoyu Tang
  • Publication number: 20240316081
    Abstract: The present disclosure discloses a method for prolonging half-life of theanine in vivo. According to the present disclosure, a specific theanine glycoside compound formed by modification with a specific monosaccharide is used for prolonging the half-life of the theanine in vivo, which can be used for preparing sustained release drugs, prolonging action time of drugs, reducing administration frequency and improving compliance of patients. With the method of the present disclosure, the theanine glycoside compound obtained after modification can have a broad application prospect and a high commercial value in scientific research and clinical application.
    Type: Application
    Filed: May 29, 2024
    Publication date: September 26, 2024
    Inventors: Yijun WANG, Zhipeng Kan, Xiaochun Wan, Jinbao Huang, Kangyi Zhang, Yunqiu Yang, Xiaoyu Tang
  • Patent number: 12091653
    Abstract: The present disclosure discloses a novel strain of Glutamicibacter, derived from insects, which efficiently degrades bifenthrin, belonging to the field of microbial strains. The Glutamicibacter CCTCC NO: M20221445 of the present disclosure was isolated from the intestinal tract of bifenthrin-resistant Ectropis grisescens Warren larvae. It exhibits unique genomic characteristics, growth and phenotypic traits, physiological and biochemical characteristics, as well as the ability to utilize and degrade bifenthrin efficiently. Specifically, it can effectively degrade bifenthrin. Based on phenotypic features, physiological and biochemical characteristics, chemical composition, and molecular biology-based polyphasic classification, Glutamicibacter CCTCC NO: M20221445 is identified as a new species. This bacterium possesses the capability to efficiently degrade bifenthrin, laying the foundation for biological control of E. grisescens and offering new microbial resources to address pesticide residue problems.
    Type: Grant
    Filed: December 1, 2023
    Date of Patent: September 17, 2024
    Assignee: ANHUI AGRICULTURAL UNIVERSITY
    Inventors: Yanhua Long, Xiayu Li, Ting Fang, Hao Gui, Meiqi Wang, Haiyue Wang, Yanru Bao, Anqi Shi, Yuhan Pan, Linlin Zhou, Xiaochun Wan, Yunqiu Yang
  • Publication number: 20240101956
    Abstract: The present disclosure discloses a novel strain of Glutamicibacter, derived from insects, which efficiently degrades bifenthrin, belonging to the field of microbial strains. The Glutamicibacter CCTCC NO: M20221445 of the present disclosure was isolated from the intestinal tract of bifenthrin-resistant Ectropis grisescens Warren larvae. It exhibits unique genomic characteristics, growth and phenotypic traits, physiological and biochemical characteristics, as well as the ability to utilize and degrade bifenthrin efficiently. Specifically, it can effectively degrade bifenthrin. Based on phenotypic features, physiological and biochemical characteristics, chemical composition, and molecular biology-based polyphasic classification, Glutamicibacter CCTCC NO: M20221445 is identified as a new species. This bacterium possesses the capability to efficiently degrade bifenthrin, laying the foundation for biological control of E. grisecens and offering new microbial resources to address pesticide residue problems.
    Type: Application
    Filed: December 1, 2023
    Publication date: March 28, 2024
    Inventors: Yanhua LONG, Xiayu Li, Ting Fang, Hao Gui, Meiqi Wang, Haiyue Wang, Yanru Bao, Anqi Shi, Yuhan Pan, Linlin Zhou, Xiaochun Wan, Yunqiu Yang